NCT01272037 2026-04-13
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Janssen Research & Development, LLC
European Organisation for Research and Treatment of Cancer - EORTC
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Sahlgrenska University Hospital
Gustave Roussy, Cancer Campus, Grand Paris